Response of Biochemical Markers of Bone Turnover to Hormone Replacement Therapy: Impact of Biological Variability
- 1 July 1998
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 13 (7), 1124-1133
- https://doi.org/10.1359/jbmr.1998.13.7.1124
Abstract
Biochemical markers of bone turnover may be useful to monitor patients taking hormone replacement therapy (HRT). The aim of this study was to assess the utility of markers in monitoring HRT by comparing the response of a large panel of markers to HRT with their within subject variability. We measured the response of markers to transdermal estradiol in 11 postmenopausal women over 24 weeks. We measured the within subject variability of markers in 11 untreated healthy postmenopausal women over the same period. The mean decrease in markers of bone formation after 24 weeks treatment ranged from 19% for procollagen type I C-terminal propeptide (PICP) to 40% for procollagen type I N-terminal propeptide (PINP). The mean decrease in markers of bone resorption ranged from 10% for tartrate-resistant acid phosphatase (TRAP) to 67% for C-terminal cross-linked telopeptide The least significant change (LSC at p < 0.05), calculated from the within subject variability in the untreated group, was used to define response. LSC for osteocalcin was 21%, bone alkaline phosphatase 28%, PICP 24%, PINP 21%, type I collagen telopeptide 28%, TRAP 17%, urinary calcium 90%, hydroxyproline 75%, total deoxypyridinoline 47%, free pyridinoline 36%, free deoxypyridinoline 26%, N-terminal cross-linked telopeptide 70%, and C-terminal cross-linked telopeptide 132%. The greatest number of responders after 24 weeks of treatment were found using PINP and osteocalcin (9 each), and free deoxypyridinoline (8 each) and total deoxypyridinoline (8 each) and total deoxypyridinoline (7 each). Lumbar spine bone mineral density defined four patients as responders. The ability to detect a response differs between markers and is not dependent on the magnitude of response to therapy.Keywords
This publication has 32 references indexed in Scilit:
- The renal clearance of free and conjugated pyridinium cross-links of collagenJournal of Bone and Mineral Research, 1996
- Both oral and transdermal estrogen increase growth hormone release in postmenopausal women--a clinical research center studyJournal of Clinical Endocrinology & Metabolism, 1996
- Biochemical markers of bone turnover to monitor the bone response to postmenopausal hormone replacement therapyOsteoporosis International, 1995
- Biological variation in bone-derived biochemical markers in serumScandinavian Journal of Clinical and Laboratory Investigation, 1995
- Impact of short-term estrogen administration on growth hormone secretion and action: Distinct route-dependent effects on connective and bone tissue metabolismJournal of Bone and Mineral Research, 1992
- Effects of a combined estrogen-gestagen regimen on serum levels of the carboxy-terminal propeptide of human type I procollagen in osteoporosisJournal of Bone and Mineral Research, 1991
- Effects of transdermal versus oral hormone replacement therapy on bone density in spine and proximal femur in postmenopausal womenThe Lancet, 1990
- A randomized study on the effects of estrogen/gestagen or high dose oral calcium on trabecular bone remodeling in postmenopausal osteoporosisBone, 1989
- Reversal of postmenopausal vertebral bone loss by oestrogen and progestogen: a double blind placebo controlled studyBMJ, 1988
- Bootstrap Methods: Another Look at the JackknifeThe Annals of Statistics, 1979